£36k
No changevs May 2024Active09604155Private limited companyOxford
GLIOTHERAPY LIMITED
Significant control: Hamesmed Limited (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Gliotherapy Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Gliotherapy Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GLIOTHERAPY LIMITED is an active private limited company (company number 09604155) incorporated on 22 May 2015, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £36k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the upper half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Hamesmed Limited
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Trizell Holding Sa
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 May 201511 yrs ago
- Next accounts due
- 28 February 2027in 123 days
- Confirmation statement due
- 5 June 2027in 220 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs May 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £36k | — | — | £17k | — | — | 0 |
| 31 May 2024 | £36k | — | — | £17k | — | — | 0 |
Current ratio0.02Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £35,998 at 31 May 2025
- Current assets below creditors within one yearCurrent ratio 0.02
- Incorporated five or more years agoIncorporated 22 May 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 220 days
- Next accounts duein 123 days
- Accounts period endNet assets £36k · micro accounts
- Accounts period endNet assets £36k · micro accounts
- Incorporated
08
Similar companies in Oxford
- BIOME OXFORD LIMITEDThame · inc. Apr 2015
- PRENOSTICS LIMITEDOxford · inc. Jul 2015
- REPLIMUNE LIMITEDAbingdon · inc. Mar 2015
- MOLECULAR WAREHOUSE LTD.Oxford · inc. Mar 2015
- SEROX LIMITEDWitney · inc. Feb 2015
- PETER KNAPP QA LIMITEDWheatley · inc. Feb 2015
All companies incorporated on 22 May 2015 · in May 2015.
09
Reminders for GLIOTHERAPY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.